Keyphrases
Lactate Dehydrogenase C
100%
Treatment Response
66%
DNA Damage
66%
Olaparib
66%
Precision Medicine
50%
Breast Cancer
50%
Cisplatin
33%
Triple-negative Breast Cancer
33%
Xenograft Mouse Model
33%
Breast Cancer Organoid
33%
Therapeutic Potential
33%
Individualized Treatment
33%
Specific Uptake
33%
Delivery System
33%
In Vivo Applications
33%
One-size-fits-all
33%
Cell Cycle Checkpoint
33%
Clinical Benefit
33%
DNA Damage Response Pathway
33%
Tumor Antigen
33%
Homing Ability
33%
Cell-penetrating Peptide
33%
DNA Repair Inhibitors
33%
Germline mutation
33%
DNA Damage Repair
33%
SiRNA Delivery
33%
BRCA1, BRCA2
33%
Breast Cancer Xenograft
33%
Tumor Cells
33%
Tumor Homing
33%
Damage Accumulation
33%
Traditional Care
33%
Homologous Recombination
33%
Homologous Recombination Deficiency
33%
Khalifa
16%
Breast Tumor
16%
Clinically Significant
16%
Tumor
16%
Breast Cancer Treatment
16%
Dysregulation
16%
Breast Cancer Cells
16%
Medicine and Dentistry
Lactate Dehydrogenase
100%
Treatment Response
50%
Cisplatin
50%
DNA Repair
50%
Olaparib
50%
Homologous Recombination
50%
Breast Cancer
50%
Personalized Medicine
50%
Neoplasm
37%
BRCA2
25%
DNA Damage Response
25%
BRCA1
25%
Cell Penetrating Peptide
25%
Tumor Antigen
25%
Cancer Cell
25%
Germline Mutation
25%
Cell Cycle Checkpoint
25%
DNA Damage
25%
Xenograft
25%
Triple Negative Breast Cancer
25%
Organoid
12%
Tumor Cell
12%
Short Hairpin RNA
12%
In Vitro
12%
Cancer Therapy
12%